Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
Are you a biotech leader striving to revolutionize obesity treatment? Discover how mastering patient engagement and retention can be the game-changer for your clinical trials.
With groundbreaking advancements in obesity care, including next-gen GLP-1s, the key to clinical success lies not just in innovation but in maintaining robust patient engagement and retention throughout complex trials. Without sustained patient engagement, even the most promising therapies risk delays, data loss, or failure to demonstrate meaningful benefit. Obesity clinical trials face unique challenges, particularly in long-duration, placebo-controlled studies, where perceived benefit, stigma, and access challenges converge to increase dropout risk.
In this candid and solutions-focused webinar, you will hear from leaders who bring both clinical and personal experience to the conversation. From mental health and “food noise” to site operations and decentralized trial design, our panelists will share practical insights on how to improve the patient experience and retain participants throughout the trial journey. You will gain strategies to enhance retention, lessen site burden, and support patients throughout the trial.
Related Insights
Article
Case study: Protecting Phase 2 obesity retention and study timelines
Mar 18, 2026
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Blog
Getting the small steps right for our biotech customers to make an exponential difference in patients’ lives
Jan 13, 2021
CTB Blog
Engage early, design once: turning early-phase trials into a program strategy
Sep 10, 2026
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
CTB Blog
Five Practical Strategies for Accelerating Early Phase Studies
Aug 19, 2026
Article
Reading current FDA and NMPA trends: What oncology tells us about the changing regulatory landscape
Jul 21, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Related Insights
Article
Case study: Protecting Phase 2 obesity retention and study timelines
Mar 18, 2026
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Blog
Getting the small steps right for our biotech customers to make an exponential difference in patients’ lives
Jan 13, 2021
CTB Blog
Engage early, design once: turning early-phase trials into a program strategy
Sep 10, 2026
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
CTB Blog
Five Practical Strategies for Accelerating Early Phase Studies
Aug 19, 2026
Article
Reading current FDA and NMPA trends: What oncology tells us about the changing regulatory landscape
Jul 21, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026